Can a Subgroup of Node-Negative Breast Carcinoma Patients With T1–2 Tumor Who May Benefit From Postmastectomy Radiotherapy be Identified?
- 1 July 2007
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 68 (4), 1024-1029
- https://doi.org/10.1016/j.ijrobp.2007.01.015
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Use of Radiotherapy After Mastectomy: A Review of the LiteratureJournal of Clinical Oncology, 2005
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- Postmastectomy Radiation Therapy: Who Needs It?Journal of Clinical Oncology, 2004
- Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*Journal of Clinical Oncology, 2001
- Importance of local tumour control in breast cancerThe Lancet Oncology, 2001
- Consensus statement on postmastectomy radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trialThe Lancet, 1999
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.Journal of Clinical Oncology, 1995